High-Frequency (30 MHz-6 GHz) Breast Tissue Characterization Stabilized by Suction Force for Intraoperative Tumor Margin Assessment
Overview
Authors
Affiliations
A gigahertz (GHz) range antenna formed by a coaxial probe has been applied for sensing cancerous breast lesions in the scanning platform with the assistance of a suction tube. The sensor structure was a planar central layer and a metallic sheath of size of 3 cm connected to a network analyzer (keySight FieldFox N9918A) with operational bandwidth up to 26.5 GHz. Cancer tumor cells have significantly higher water content (as a dipolar molecule) than normal breast cells, changing their polarization responses and dielectric losses to incoming GHz-based stimulation. Principal component analysis named , related to the dispersion ratio of the input signal, is used as a parameter to identify malignant tumor cells in a mouse model (in vivo) and tumor specimens of breast cancer patients (in vitro) (both central and marginal parts). The results showed that values in the frequency range from 5 to 6 GHz were significantly higher in cancer-involved breast lesions. Histopathological analysis was the gold standard for achieving the calibration to distinguish normal from cancerous lesions. Our calibration on tumor specimens presented 82% positive predictive value (PPV), 100% negative predictive value (NPV), and 86% accuracy. Our goal is to apply this system as an in vivo non-invasive tumor margin scanner after further investigations in the future.
ATP-Binding Cassette Transporter Genes and microRNAs in Pediatric B-Cell ALL: Expression Insights.
Nekouian R, Faranoush P, Khesali F, Shams P, Foroughi-Gilvaee M, Sadighnia N J Clin Lab Anal. 2024; 39(1):e25134.
PMID: 39714045 PMC: 11737115. DOI: 10.1002/jcla.25134.
Canicatti E, Alvarez Sanchez-Bayuela D, Romero Castellano C, Aguilar Angulo P, Giovanetti Gonzalez R, Cruz Hernandez L Diagnostics (Basel). 2023; 13(18).
PMID: 37761382 PMC: 10527865. DOI: 10.3390/diagnostics13183015.
DAlvia L, Peruzzi B, Apa L, Del Prete Z, Rizzuto E Bioengineering (Basel). 2023; 10(8).
PMID: 37627792 PMC: 10452017. DOI: 10.3390/bioengineering10080907.